LORELEI PUNSALAN: Open Payments
NPI 1679990618 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,549 in 56 payments from 24 companies in 2025. Trend: 2023 $1,964 · 2024 $1,988 · 2025 $2,549
Food & beverage: $2,549
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $308 |
| ABIOMED | 2 | $270 |
| UCB, Inc. | 5 | $242 |
| Novartis Pharmaceuticals Corporation | 7 | $214 |
| Biosense Webster, Inc. | 1 | $147 |
| PFIZER INC. | 7 | $145 |
| Abbott Laboratories | 1 | $139 |
| Regeneron Healthcare Solutions, Inc. | 1 | $130 |
| SK Life Science, Inc. | 4 | $129 |
| ACADIA Pharmaceuticals Inc | 2 | $118 |
Products named: KRYSTEXXA, Rystiggo, KESIMPTA, NUVISION ICE CATHETER, LEQEMBI, INFINITY, DUPIXENT, NUPLAZID.
Industry payments across CA — which companies pay providers there.
